HEADER VIRAL PROTEIN 03-APR-23 8IXZ TITLE STRUCTURE OF ACB2 COMPLEXED WITH 3',2'-CGAMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: P26; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: ACB2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS PHAGE PAP2; SOURCE 3 ORGANISM_TAXID: 270673; SOURCE 4 GENE: ORF26; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTI-CBASS PROTEIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.L.CAO,Y.XIAO,Y.FENG REVDAT 2 28-FEB-24 8IXZ 1 REMARK REVDAT 1 07-FEB-24 8IXZ 0 JRNL AUTH X.CAO,Y.XIAO,E.HUITING,X.CAO,D.LI,J.REN,I.FEDOROVA,H.WANG, JRNL AUTH 2 L.GUAN,Y.WANG,L.LI,J.BONDY-DENOMY,Y.FENG JRNL TITL PHAGE ANTI-CBASS PROTEIN SIMULTANEOUSLY SEQUESTERS CYCLIC JRNL TITL 2 TRINUCLEOTIDES AND DINUCLEOTIDES. JRNL REF MOL.CELL V. 84 375 2024 JRNL REFN ISSN 1097-2765 JRNL PMID 38103556 JRNL DOI 10.1016/J.MOLCEL.2023.11.026 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20_4459: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 27455 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1370 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.7900 - 5.0000 1.00 2759 146 0.2024 0.2304 REMARK 3 2 5.0000 - 3.9800 1.00 2656 139 0.2091 0.2137 REMARK 3 3 3.9800 - 3.4800 1.00 2621 139 0.2187 0.3079 REMARK 3 4 3.4700 - 3.1600 1.00 2599 139 0.2545 0.2968 REMARK 3 5 3.1600 - 2.9300 1.00 2633 138 0.2426 0.2708 REMARK 3 6 2.9300 - 2.7600 1.00 2572 137 0.2889 0.3692 REMARK 3 7 2.7600 - 2.6200 0.99 2580 135 0.2574 0.3200 REMARK 3 8 2.6200 - 2.5100 0.99 2571 138 0.2681 0.3429 REMARK 3 9 2.5100 - 2.4100 0.99 2555 134 0.2444 0.3067 REMARK 3 10 2.4100 - 2.3300 0.98 2539 125 0.2741 0.3266 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 4762 REMARK 3 ANGLE : 2.484 6450 REMARK 3 CHIRALITY : 0.105 697 REMARK 3 PLANARITY : 0.032 805 REMARK 3 DIHEDRAL : 15.665 847 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8IXZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-APR-23. REMARK 100 THE DEPOSITION ID IS D_1300036719. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27614 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 17.60 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.10 REMARK 200 R MERGE FOR SHELL (I) : 0.58400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM BROMIDE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 101.14100 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 101.14100 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 101.14100 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -52.02250 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 90.10561 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -104.04500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -52.02250 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 90.10561 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -104.04500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 224 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP B 2 REMARK 465 ASP C 2 REMARK 465 ASP D 2 REMARK 465 ASP E 2 REMARK 465 ASP F 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 227 O HOH A 229 1.97 REMARK 500 O HOH A 225 O HOH A 228 1.99 REMARK 500 O LEU A 51 O HOH A 201 2.03 REMARK 500 N ASP A 2 O HOH A 202 2.06 REMARK 500 O HOH D 211 O HOH D 219 2.06 REMARK 500 O HOH D 216 O HOH D 218 2.08 REMARK 500 O GLU D 17 O HOH D 201 2.09 REMARK 500 OE1 GLU F 64 O HOH F 101 2.09 REMARK 500 O HOH D 214 O HOH D 215 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 GLN B 4 N LEU B 14 6555 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 89 71.74 53.42 REMARK 500 GLN B 89 71.65 52.73 REMARK 500 HIS C 52 -6.02 80.61 REMARK 500 GLN C 89 73.60 53.57 REMARK 500 HIS D 52 1.27 82.55 REMARK 500 GLN D 89 71.79 51.61 REMARK 500 HIS E 52 -1.37 78.89 REMARK 500 ARG E 54 -57.03 74.24 REMARK 500 GLN E 89 72.23 53.16 REMARK 500 ASP E 91 44.11 -102.32 REMARK 500 ARG F 54 -6.51 78.66 REMARK 500 REMARK 500 REMARK: NULL DBREF 8IXZ A 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 DBREF 8IXZ B 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 DBREF 8IXZ C 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 DBREF 8IXZ D 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 DBREF 8IXZ E 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 DBREF 8IXZ F 2 93 UNP Q6PVL0 Q6PVL0_9CAUD 2 93 SEQRES 1 A 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 A 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 A 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 A 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 A 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 A 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 A 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 A 92 PHE SEQRES 1 B 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 B 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 B 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 B 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 B 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 B 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 B 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 B 92 PHE SEQRES 1 C 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 C 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 C 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 C 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 C 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 C 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 C 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 C 92 PHE SEQRES 1 D 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 D 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 D 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 D 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 D 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 D 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 D 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 D 92 PHE SEQRES 1 E 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 E 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 E 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 E 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 E 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 E 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 E 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 E 92 PHE SEQRES 1 F 92 ASP ASN GLN HIS LYS LYS ILE LYS GLY TYR ARG ASP LEU SEQRES 2 F 92 SER GLN GLU GLU ILE ASP MET MET ASN ARG VAL LYS GLU SEQRES 3 F 92 LEU GLY SER GLN PHE GLU LYS LEU ILE GLN ASP VAL SER SEQRES 4 F 92 ASP HIS LEU ARG GLY GLN TYR ASN ALA SER LEU HIS ASN SEQRES 5 F 92 ARG ASP GLU ILE THR ARG ILE ALA ASN ALA GLU PRO GLY SEQRES 6 F 92 ARG TRP LEU ALA ILE GLY LYS THR ASP ILE GLN THR GLY SEQRES 7 F 92 MET MET ALA ILE ILE ARG ALA ILE ALA GLN PRO ASP SER SEQRES 8 F 92 PHE HET 4UR A 101 45 HET 4UR B 101 45 HET 4UR D 101 90 HET 4UR E 101 90 HETNAM 4UR 3'2'-CGAMP HETSYN 4UR 2-AMINO-9-[(2S,5R,7R,8R,10R,12AR,14R,15R,15AS,16R)-7- HETSYN 2 4UR (6-AMINO-9H-PURIN-9-YL)-2,10,15,16-TETRAHYDROXY-2,10- HETSYN 3 4UR DIOXIDOOCTAHYDRO-12H-5,8-METHANOFURO[3,2-L][1,3,6,9, HETSYN 4 4UR 11,2,10]PENTAOXADIPHOSPHACYCLOTETRADECIN-14-YL]-1,9- HETSYN 5 4UR DIHYDRO-6H-PURIN-6-ONE FORMUL 7 4UR 4(C20 H24 N10 O13 P2) FORMUL 11 HOH *73(H2 O) HELIX 1 AA1 ASN A 3 ILE A 8 5 6 HELIX 2 AA2 SER A 15 SER A 50 1 36 HELIX 3 AA3 ASN A 53 GLU A 64 1 12 HELIX 4 AA4 GLU A 64 GLN A 89 1 26 HELIX 5 AA5 GLN B 4 ILE B 8 1 5 HELIX 6 AA6 SER B 15 SER B 50 1 36 HELIX 7 AA7 ASN B 53 GLU B 64 1 12 HELIX 8 AA8 GLU B 64 GLN B 89 1 26 HELIX 9 AA9 GLN C 4 ILE C 8 1 5 HELIX 10 AB1 SER C 15 SER C 50 1 36 HELIX 11 AB2 ASN C 53 GLU C 64 1 12 HELIX 12 AB3 GLU C 64 GLN C 89 1 26 HELIX 13 AB4 ASN D 3 ILE D 8 5 6 HELIX 14 AB5 SER D 15 LEU D 51 1 37 HELIX 15 AB6 ASN D 53 GLU D 64 1 12 HELIX 16 AB7 GLU D 64 GLN D 89 1 26 HELIX 17 AB8 GLN E 4 ILE E 8 5 5 HELIX 18 AB9 SER E 15 SER E 50 1 36 HELIX 19 AC1 ARG E 54 GLU E 64 1 11 HELIX 20 AC2 GLU E 64 GLN E 89 1 26 HELIX 21 AC3 SER F 15 SER F 50 1 36 HELIX 22 AC4 ASP F 55 GLU F 64 1 10 HELIX 23 AC5 GLU F 64 GLN F 89 1 26 CRYST1 104.045 104.045 101.141 90.00 90.00 120.00 P 3 2 1 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009611 0.005549 0.000000 0.00000 SCALE2 0.000000 0.011098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009887 0.00000